Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för Ro 5-3335. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2014-03-20

Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA.

Klase Z, Yedavalli VS, Houzet L, Perkins M, Maldarelli F, Brenchley J, Strebel K, Liu P, Jeang KT.

PLoS Pathog · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.ppat.1003997

Bibliografisk träff 2012-08-21

Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.

Cunningham L, Finckbeiner S, Hyde RK, Southall N, Marugan J, Yedavalli VR, Dehdashti SJ, Reinhold WC, Alemu L, Zhao L, Yeh JR, Sood R, Pommier Y, Austin CP, Jeang KT, Zheng W, Liu P.

Proc Natl Acad Sci U S A · research support, n.i.h., intramural; research-article; journal article; research support, n.i.h., extramural · DOI 10.1073/pnas.1200037109

Bibliografisk träff 1995-04-01

The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter.

Cupelli LA, Hsu MC.

J Virol · research-article; journal article · DOI 10.1128/jvi.69.4.2640-2643.1995

Bibliografisk träff 1994-09-01

HIV replication in chronically infected macrophages is not inhibited by the Tat inhibitors Ro-5-3335 and Ro-24-7429.

Dunne AL, Siregar H, Mills J, Crowe SM.

J Leukoc Biol · research support, non-u.s. gov't; journal article · DOI 10.1002/jlb.56.3.369

Bibliografisk träff 1993-03-01

[Therapeutic potential of Ro 5-3335. New active benzodiazepine in vitro against HIV-1 viruses resistant or non-resistant to AZT].

Camsonne R, Bigot MC, Fusibet H, Moulin MA.

Therapie · journal article; english abstract

Bibliografisk träff 1992-12-01

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.

Witvrouw M, Pauwels R, Vandamme AM, Schols D, Reymen D, Yamamoto N, Desmyter J, De Clercq E.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.36.12.2628

Bibliografisk träff 1992-11-01

Disposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.

Town C, Chang D, Henderson L, Garland WA.

Drug Metab Dispos · journal article · DOI 10.1016/s0090-9556(25)08820-8

Bibliografisk träff 1992-05-01

Discovery and characterization of an HIV-1 Tat antagonist.

Hsu MC, Schutt AD, Holly M, Slice LW, Sherman MI, Richman DD, Potash MJ, Volsky DJ.

Biochem Soc Trans · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1042/bst0200525